Search - tctmd.com

Displaying 141 - 160 of 297

Sort: Relevancy | Date

News Conference News AHA 2017

Survey Says: Interventionalists Believe Public Reporting Leads to High-Risk PCI Avoidance, Upcoding

Yael L. Maxwell

November 15, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Conference News AHA 2017

Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery

Shelley Wood

November 14, 2017

News Conference News AHA 2017

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Yael L. Maxwell

November 14, 2017

Presentation AHA 2017

Impact of Regionalization of ST Elevation Myocardial Infarction Care

Presenter: James G. Jollis

November 14, 2017

News Conference News AHA 2017

One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs

Shelley Wood

November 14, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

Presentation AHA 2017

Subgroup Analysis from the RE-DUAL PCI Trial

Presenter: Jonas Oldgren

November 14, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

Todd Neale

November 12, 2017

News Conference News AHA 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Todd Neale

November 11, 2017

Presentation AHA 2017

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

Presenter: Zuzana Motovska

November 11, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Daily News

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

Michael O'Riordan

June 28, 2017

News Daily News

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Michael O'Riordan

May 30, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

News Daily News

One in Five Acute MI Patients Drop Statins Within 2 Years

Michael O'Riordan

April 20, 2017

Advertisement

Survey Says: Interventionalists Believe Public Reporting Leads to High-Risk PCI Avoidance, Upcoding

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Impact of Regionalization of ST Elevation Myocardial Infarction Care

One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Subgroup Analysis from the RE-DUAL PCI Trial

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

New Performance and Quality Metrics for STEMI and NSTEMI Care

TCTMD’s Top 10 Most Popular Stories for June 2017

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

One in Five Acute MI Patients Drop Statins Within 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content